PRISM BioLab Co.,LTD (206A.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−4.7x

Market Cap

JPY 6.38B

MomentumView details →

1D Return

+1.17%

YTD Return

+11.54%

RSI (14)

58.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−4.7x

Market Cap

JPY 6.38B

RSI (14)

58.3

MomentumView details →

1D Return

+1.17%

YTD Return

+11.54%

ProfitabilityView details →

Gross Margin

39.44%

Net Margin

−135.53%

EBITDA Margin

—

ROE (TTM)

−38.01%

ROA (TTM)

−30.88%

Asset Turnover

0.22x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+121.97%

EPS CAGR 3Y

+31.94%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

5.31x

Quick Ratio

5.31x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

684.00M

Net Income (TTM)

−927.00M

Op. CF (TTM)

—

Next earningsNov 13, 2026 →

Latest newsMore news →

PRISM BioLab announced its financial results for the third quarter of fiscal year ending September 2026, reporting a net loss of 840 million yen for the cumulative nine months (October 2025-June 2026), widening from an 800 million yen loss a year earlier, while the April-June quarter net loss narrowed to 240 million yen from 320 million yen.22d ago

Similar companies

Noile-Immune Biotech Inc.4893.T J-Pharma Co.,Ltd.520A.T CellSource Co.,Ltd.4880.T Solasia Pharma K.K.4597.T BrightPath Biotherapeutics Co.,Ltd.4594.T NIPPON CHEMIPHAR CO.,LTD.4539.T Find similar companies →

Latest newsMore news →

PRISM BioLab announced its financial results for the third quarter of fiscal year ending September 2026, reporting a net loss of 840 million yen for the cumulative nine months (October 2025-June 2026), widening from an 800 million yen loss a year earlier, while the April-June quarter net loss narrowed to 240 million yen from 320 million yen.22d ago